Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’
Fox News
Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.
The researchers analyzed three years of medical records for nearly one million type 2 diabetes patients in the U.S. "GLP-1s treat insulin resistance, which has a positive impact on the whole body – including better cognitive function." "Most age-related conditions share common underpinnings — it’s simply a matter of geography." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The findings were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association on Thursday.